The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 1b trial of mFOLFOX6 and everolimus (NSC-733504) in patients with metastatic gastroesophageal adenocarcinoma (NCT01231399).
Vincent M. Chung
Research Funding - Novartis
Paul Henry Frankel
No relevant relationships to disclose
Dean Lim
No relevant relationships to disclose
Joseph Chao
No relevant relationships to disclose
Christina Haeyoung Yeon
No relevant relationships to disclose
Lucille A. Leong
No relevant relationships to disclose
Joseph Kim
No relevant relationships to disclose
Eloise Luevanos
No relevant relationships to disclose
Carol Rose
No relevant relationships to disclose
Marwan Fakih
No relevant relationships to disclose